Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation.

Stedman MPeter TaylorLakdasa PremawardhanaOnyebuchi OkosiemeColin DayanAdrian H Heald

Published in: International journal of clinical practice (2021)

In spite of strenuous attempts to limit prescribing of liothyronine in general practice a significant number of patients continue to receive this therapy, although there is significant geographical variation in the prescribing of this as for levothyroxine, with specific general practice and CCG-related factors influencing prescribing of both levothyroxine and liothyronine across England.

Keyphrases

general practice
primary care
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
adverse drug
prognostic factors
emergency department
peritoneal dialysis
mesenchymal stem cells
cross sectional
bone marrow